Hemal Exim Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 02-07-2024
- Paid Up Capital ₹ 1.50 M
as on 02-07-2024
- Company Age 37 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.35 Cr
as on 02-07-2024
- Revenue -30.45%
(FY 2023)
- Profit -88.89%
(FY 2023)
- Ebitda 28.13%
(FY 2023)
- Net Worth 1.42%
(FY 2023)
- Total Assets 4.70%
(FY 2023)
About Hemal Exim
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.35 Cr.
Satya Rathore, Rinviz Palkhiwala, and Peter Dessa serve as directors at the Company.
- CIN/LLPIN
U99999MH1987PTC044590
- Company No.
044590
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Hemal Exim Pvt Ltd offer?
Hemal Exim Pvt Ltd offers a wide range of products and services, including Granite, Marble, Sandstone & Others, Sedimentary Stone, Wall Panels, Charcoal Wall Panels, Paver, Paving Stone, Building Panels & Cladding Materials, Wall & Roof Panels, Cladding Sheets & Panels.
Who are the key members and board of directors at Hemal Exim?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satya Rathore  | Director | 17-Oct-2013 | Current |
| Rinviz Palkhiwala | Director | 07-Sep-2001 | Current |
| Peter Dessa | Director | 10-Oct-2001 | Current |
Financial Performance of Hemal Exim.
Hemal Exim Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.45% decrease. The company also saw a substantial fall in profitability, with a 88.89% decrease in profit. The company's net worth moved up by a moderate rise of 1.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hemal Exim?
In 2023, Hemal Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Golden Triangle Fort And Palace Private LimitedActive 25 years 9 monthsPeter Dessa is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 23 Dec 2005 | ₹0.75 M | Open |
Canara Bank Creation Date: 06 Nov 2001 | ₹6.75 M | Open |
Canara Bank Creation Date: 02 Dec 1994 | ₹6.00 M | Open |
How Many Employees Work at Hemal Exim?
Unlock and access historical data on people associated with Hemal Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hemal Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemal Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
